Xarelto Claims and Legal Compensation

Xarelto is an anticoagulant (blood thinner) which blocks the activity of specific substances that are responsible for blood clotting. Although blood clotting is a natural process that helps in healing, the clots can also be form abnormally, break away into the blood stream and obstruct the flow of blood into body organs.  Manufactured by Bayer and was released in the U.S. in 2011 by Janssen Pharmaceuticals, Inc., a subsidiary of Johnson & Johnson, Xarelto was designed to prevent or treat a type of blood clot called deep vein thrombosis (DVT) or pulmonary embolism (blood clots in the lungs, brain or heart). It is generally prescribed for patients undergoing certain types of surgeries, such as hip or knee replacement. However, there have been complications reported by the patients after taking the drug. They claimed for  xarelto legal compensation for all the pain and suffering. Initially, Xarelto was marketed as a superior anticoagulant to other existi

Brought onto the market in 2011, Xarelto is a new classification of blood thinners for patients who are at risk of forming blood clots. Xarelto, the trade name of the drug rivaroxaban is produced by Janssen Pharmaceuticals, Inc. (a Johnson & Johnson company), under license from Bayer HealthCare. It was approved by the Food and Drug Administration (FDA) of the US to treat patients suffering from risk of stroke and systemic embolism with non-valvular atrial fibrillation, specially after hip and knee replacement surgery. Belonging to a class of medications called factor Xa inhibitors, it was initially thought to be a revolutionary alternative. But soon after patients complained about the side effects and the victims filed for xarelto lawsuits . The most pertinent danger of the drug While internal bleeding is a risk of any blood thinner might have, emergency antidotes are available for the existing drugs. There is no known antidote for Xarelto, whic